Medivo Raises $15 Million Series B For Mobile Health Monitoring

6-17-2013 11-09-42 PM

New York-based Health Startup Medivo has announced a $15 million Series B round led by the Merck Global Health Innovation Fund, Safeguard Scientifics and MentorTech Ventures. The round follows a $7 million Series A round in 2011 that was also led by Safeguard Scientifics and MentorTech Ventures.

Founded in 2010 by former MedSite CEO, Medivo strives to provide health monitoring to connect doctors, consumers, and clinical lab data. The applications are designed to help patients track key symptoms and labs and correlate the data with key behaviors like diet and medication compliance. On the physician side, patients are sorted by symptoms and labs to quickly identify who needs outreach support and who is doing well.

The platform has been designed to support patients with diabetes, dyslipidemia, hepatitis C, gout, low testosterone, IBS, hereditary angioedema, and chronic myelogenous leukemia. The financing will expand this to include obesity, rheumatoid arthritis, hepatitis B, HIV, additional cancers, osteoporosis, and MS.

↑ Back to top

Founding Sponsors

Platinum Sponsors